Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Baxter
QuintilesIMS
Colorcon
Covington
Johnson and Johnson

Generated: June 16, 2019

DrugPatentWatch Database Preview

Drug Price Trends for ATENOLOL

« Back to Dashboard

Drug Price Trends for ATENOLOL

Average Pharmacy Cost for ATENOLOL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Glossary
Drug Name NDC Price/Unit ($) Unit Date
ATENOLOL-CHLORTHALIDONE 100-25 70710-1168-01 0.59217 EACH 2019-06-05
ATENOLOL-CHLORTHALIDONE 50-25 70710-1167-01 0.40715 EACH 2019-06-05
ATENOLOL 100 MG TABLET 00378-0757-01 0.03584 EACH 2019-05-22
ATENOLOL 100 MG TABLET 00378-0757-10 0.03584 EACH 2019-05-22
Drug Name NDC Price/Unit ($) Unit Date

Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for ATENOLOL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
ATENOLOL 25MG TAB AvKare, Inc. 42291-0140-10 1000 14.10 0.01410 EACH 2018-01-01 - 2022-12-31 FSS
ATENOLOL 50MG TAB AvKare, Inc. 42291-0141-10 1000 24.40 0.02440 EACH 2018-01-01 - 2022-12-31 FSS
ATENOLOL 50MG TAB AvKare, Inc. 42291-0141-10 1000 23.68 0.02368 EACH 2018-05-18 - 2022-12-31 FSS
ATENOLOL 100MG TAB AvKare, Inc. 42291-0142-50 500 17.97 0.03594 EACH 2018-01-01 - 2022-12-31 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Deloitte
Johnson and Johnson
Harvard Business School
Healthtrust
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: